ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SKIN vs MBOT // REVENUE GROWTH (YOY)

SkinHealth Systems Inc. (Class A) (NASDAQ) VS. Microbot Medical Inc. (NASDAQ) • 15-METRIC TALLY: SKIN 1 — MBOT 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SKIN VS. MBOT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SKIN MBOT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 65.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -26.90% -15.80% -11.10 MBOT /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -17.42% — TIE /fcf-yield <GO>
Operating Margin -6.90% — — TIE /operating-margins <GO>
Net Profit Margin -3.20% — — TIE /net-margins <GO>
Revenue Growth (YoY) ACTIVE -10.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 2/9 +4.00 SKIN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 35.8 48.5 -12.70 MBOT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $66.0M $75.2M -$9.2M MBOT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SKIN REV MBOT REV SKIN GROSS % MBOT GROSS % SKIN FCF MBOT FCF
FY 2025 $300.8M $0 65.3% — $37.2M -$13.1M
FY 2024 $334.3M $0 54.5% — $15.4M -$8.9M
FY 2023 $398.0M $0 — — $21.8M -$8.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SKIN // BETA —
MBOT // BETA —